Navigation Links
ZeptoMetrix™ Corporation (ZMC) Announces the Release of Additional Zika Virus Culture Fluids
Date:5/17/2016

ZeptoMetrix™ Corporation (ZMC), announced today the release of 3 additional Zika Virus Strains to its product inventory to aid in the rapid development of diagnostic tests and for the manufacture of quality control reagents to monitor their effectiveness.

“We are offering as much support as possible to assist during this global Zika virus emergency”, explains Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix. “Our focus, has always been and will continue to be to support the diagnostics industry with as many precise, dependable and non-infectious tools as we can.”

To complement its currently expanding Tropical Disease Microorganism offerings (http://www.zeptometrix.com), ZeptoMetrix has introduced the following Zika Virus Culture Fluids to its product line:

Zika Virus (Strain: PRVABC59) Culture Fluid (1 mL) - # 0810525CF
Zika Virus (Strain: DakArD 41662) Culture Fluid (1 mL) - # 0810522CF
Zika Virus (Strain: MR 766) Culture Fluid (1 mL) - # 0810521CF

Using its proprietary NATtrol™ inactivation treatment, ZeptoMetrix has also released noninfectious, whole organism molecular quality controls and an assay range validation panel that can be used in clinical laboratories for daily test variation, lot-to-lot test kit performance, individual operator performance and assistance identifying trends in laboratory results.

NATtrol Zika Virus Range Verification Panel (4 x 0.5 mL) - # NATZIKV-RV
NATtrol Zika Virus, External Run Control, Medium (6 x 1 mL) - # NATZIKV-ERCM
NATtrol Zika Virus, External Run Control, Low (6 x 1 mL) - # NATZIKV-ERCL

Together, the routine and repetitive use of NATtrol™ External Run Controls and Range Verification Panels enables laboratories to verify test performance, track and monitor daily test variation, lot-to-lot test kit performance, individual operator performance to provide assistance identifying trends in laboratory results.

About ZeptoMetrix™:

ZeptoMetrix Corporation (ZMC) is a renowned industry leader and innovator identified with quality, reliable and trusted products and services for infectious disease diagnostic development. ZeptoMetrix is a fully integrated biotechnology company whose offerings support all phases of research & development, validation, manufacturing and commercialization of diagnostic testing.

Founded in 1999, ZeptoMetrix is headquartered in Buffalo, NY with additional facilities in Franklin, Massachusetts.

For Sales and/or information regarding Zika Virus Products, related Tropical Disease Products as well as other ZeptoMetrix Product Lines, please contact ZeptoMetrix Customer Relations directly.

Read the full story at http://www.prweb.com/releases/2016/05/prweb13416725.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. ZeptoMetrix™ (ZMC) to Release NATtrol™ Inactivated Zika Virus for the Development of Molecular Diagnostic Assays and Ongoing Clinical Laboratory Quality Control
2. Celsion Corporation to Hold First Quarter 2016 Financial Results Conference Call on Monday, May 16, 2016
3. United Therapeutics Corporation To Present At Deutsche Bank 41st Annual Health Care Conference
4. Seattle based non-profit, The Institute for Venture Science (IVS) today announced receipt of a significant operating grant from 1Plus12 Corporation.
5. Celsion Corporation Announces Enrollment of First Patient in the OPTIMA Study in China
6. United Therapeutics Corporation To Announce First Quarter 2016 Financial Results Before Market Open On Thursday, April 28, 2016
7. Cognition Corporation Releases Guided Template for PHA Compliance
8. Celsion Corporation Reports Year End 2015 Financial Results and Provides Business Update
9. Native Traits Corporation Announces the Launch of its EaSY (TM) Inbred Line Conversion Program
10. OHAUS Corporation Unveils New Laboratory Balances and Electrochemistry Meters At Pittcon 2016
11. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... Basel, Switzerland (PRWEB) , ... May 23, 2017 ... ... for R&D, celebrates this month its 20th anniversary, marking the occasion with a ... is sponsoring the meeting’s Welcome Reception and further extends an invitation to all ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... ... publication of “Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology ... the result of a collaboration with Dr. Dino Di Carlo and Dr. Matthew Rettig ...
(Date:5/23/2017)... , ... May 23, 2017 , ... Bacterial biofilms, surface ... molecules, can cause diverse pathologies ranging from food poisoning and catheter infections to gum ... is in the tens of billions of dollars per year, there is currently a ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Stratevi, a ... expanded to the East Coast. It has opened an office in downtown Boston at ... are finding it increasingly more important to generate evidence on the value they provide, ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):